scispace - formally typeset
J

Jinzhong Qin

Researcher at Cleveland Clinic

Publications -  14
Citations -  5224

Jinzhong Qin is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Receptor & Signal transduction. The author has an hindex of 10, co-authored 10 publications receiving 4802 citations. Previous affiliations of Jinzhong Qin include Cleveland State University.

Papers
More filters
Journal ArticleDOI

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

TL;DR: A member of theIL-1 family, IL-33, which mediates its biological effects via IL-1 receptor ST 2, activates NF-kappaB and MAP kinases, and drives production of T(H)2-associated cytokines from in vitro polarized T( H)2 cells is reported.
Journal ArticleDOI

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.

TL;DR: Inflammation is enhanced in SIGIRR-deficient mice, as shown by their enhanced chemokine induction after IL-1 injection and reduced threshold for lethal endotoxin challenge and biochemical analysis indicated that SIGirR binds to the TLR–IL-1R signaling components in a ligand-dependent way.
Journal ArticleDOI

SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms.

TL;DR: Results indicate that SIGIRR inhibits IL-1 and LPS signaling pathways through differential mechanisms.
Journal ArticleDOI

Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex.

TL;DR: A mammalian counterpart of Pellino is reported, termed Pellino 1, which is required for NFκB activation and IL-8 gene expression in response to IL-1, probably through its signal-dependent interaction with IRAK4, IRAK, and the tumor necrosis factor receptor-associated factor 6 (TRAF6).